Moreover, higher expression of TOX2, TOX3, and TOX4 of AML patients and the AML patients with highly co-expressed TOX, TOX2, TOX4 genes were associated with poor OS for AML patients, which may be related to the upregulation of immune checkpoint genes. The gene discussed is TOX4; the disease is acute myeloid leukemia.